Dong-A ST Achieves Therapeutic Equivalence With Stelara Biosimilar

Company Aims To Submit EU and US Marketing Authorization During H1

 
• By Chloe Kent
  
Graphic reading 'Clinical Trial'
• Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Products

More from Generics Bulletin